IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $1.34 $2.47 Friday, 12th Apr 2024 AKBA stock ended at $1.46. This is 4.58% less than the trading day before Thursday, 11th Apr 2024. During the day the stock fluctuated 8.45% from a day low at $1.42 to a day high of $1.54.
90 days $1.29 $2.47
52 weeks $0.590 $2.47

Historical Akebia Therapeutics prices
JSON

CSV

Date Open High Low Close Volume
2024-04-12 $1.52 $1.54 $1.42 $1.46 4 080 961
2024-04-11 $1.55 $1.55 $1.47 $1.53 3 098 737
2024-04-10 $1.58 $1.62 $1.52 $1.56 5 369 993
2024-04-09 $1.50 $1.56 $1.47 $1.54 2 849 935
2024-04-08 $1.48 $1.54 $1.42 $1.53 3 702 802
2024-04-05 $1.51 $1.56 $1.48 $1.49 3 474 296
2024-04-04 $1.48 $1.60 $1.46 $1.51 6 016 799
2024-04-03 $1.59 $1.59 $1.43 $1.49 8 504 274
2024-04-02 $1.55 $1.61 $1.47 $1.58 8 012 403
2024-04-01 $1.88 $1.93 $1.55 $1.63 14 012 870
2024-03-28 $2.46 $2.47 $1.77 $1.83 60 390 756
2024-03-27 $2.06 $2.34 $2.05 $2.24 8 863 495
2024-03-26 $2.20 $2.22 $1.91 $2.00 9 902 802
2024-03-25 $2.24 $2.33 $2.15 $2.21 8 398 310
2024-03-22 $2.07 $2.24 $2.02 $2.17 7 758 636
2024-03-21 $1.96 $2.08 $1.95 $2.04 6 497 237
2024-03-20 $1.87 $1.94 $1.78 $1.94 5 153 908
2024-03-19 $1.88 $1.94 $1.80 $1.83 4 310 241
2024-03-18 $1.76 $2.05 $1.70 $1.89 9 467 683
2024-03-15 $1.60 $1.82 $1.52 $1.70 13 482 326
2024-03-14 $1.43 $1.43 $1.34 $1.37 2 435 516
2024-03-13 $1.45 $1.50 $1.41 $1.41 2 054 291
2024-03-12 $1.45 $1.45 $1.36 $1.42 3 348 839
2024-03-11 $1.52 $1.55 $1.43 $1.44 3 146 006
2024-03-08 $1.49 $1.57 $1.45 $1.47 2 372 773
Click to get the best stock tips daily for free!

About Akebia Therapeutics

Akebia Therapeutics Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra... AKBA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT